Skip to main content
. 2018 Oct 10;17(1):532–538. doi: 10.3892/ol.2018.9565

Figure 2.

Figure 2.

The frequency of MIS/AMHRII expression in proliferative healthy human endometria, secretory healthy human endometria, simple endometrial hyperplasia without atypia, complex endometrial hyperplasia without atypia, simple endometrial hyperplasia with atypia, complex endometrial hyperplasia with atypia and endometrial cancer. MIS/AMHRII, Mullerian inhibiting substance/anti-Müllerian hormone type II receptor.